Detailed information for compound 1052863

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 468.456 | Formula: C23H22F2N6O3
  • H donors: 2 H acceptors: 4 LogP: 3.23 Rotable bonds: 4
    Rule of 5 violations (Lipinski): 1
  • SMILES: CCn1cc(c2[nH]c3c(n2)ccc(c3)[N+](=O)[O-])c(=O)c2c1c(F)c(N1CCNC(C1)C)c(c2)F
  • InChi: 1S/C23H22F2N6O3/c1-3-29-11-15(23-27-17-5-4-13(31(33)34)8-18(17)28-23)22(32)14-9-16(24)21(19(25)20(14)29)30-7-6-26-12(2)10-30/h4-5,8-9,11-12,26H,3,6-7,10H2,1-2H3,(H,27,28)
  • InChiKey: RZZFBQBYOJVYAG-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Trichomonas vaginalis chromodomain helicase DNA binding protein, putative 0.0006 0.0542 0.1789
Plasmodium vivax AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative 0.002 0.2948 1
Trichomonas vaginalis chromodomain helicase DNA binding protein, putative 0.0006 0.0542 0.1789
Schistosoma mansoni carbon catabolite repressor protein 0.0004 0.0125 0.0125
Trichomonas vaginalis type IV inositol 5-phosphatase, putative 0.0004 0.0125 0.0366
Mycobacterium tuberculosis Probable exodeoxyribonuclease III protein XthA (exonuclease III) (EXO III) (AP endonuclease VI) 0.002 0.2948 1
Echinococcus granulosus cpg binding protein 0.003 0.4688 0.5784
Entamoeba histolytica endonuclease/exonuclease/phosphatase family protein 0.0004 0.0125 0.0424
Schistosoma mansoni mixed-lineage leukemia protein mll 0.0007 0.0651 0.0651
Brugia malayi F/Y-rich N-terminus family protein 0.0009 0.0936 0.1028
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.0048 0.8014 0.8014
Schistosoma mansoni synaptojanin 0.0004 0.0125 0.0125
Leishmania major apurinic/apyrimidinic endonuclease-redox protein 0.002 0.2948 1
Entamoeba histolytica sphingomyelinase C precursor, putative 0.0004 0.0125 0.0424
Trichomonas vaginalis chromodomain-helicase-DNA-binding protein, putative 0.0006 0.0542 0.1789
Treponema pallidum exodeoxyribonuclease (exoA) 0.002 0.2948 1
Echinococcus multilocularis cpg binding protein 0.003 0.4688 0.5784
Entamoeba histolytica endonuclease/exonuclease/phosphatase family protein 0.0004 0.0125 0.0424
Trichomonas vaginalis conserved hypothetical protein 0.0006 0.0542 0.1789
Echinococcus multilocularis mixed lineage leukemia protein mll 0.0007 0.0651 0.0667
Trichomonas vaginalis chromodomain helicase DNA binding protein, putative 0.0006 0.0542 0.1789
Trichomonas vaginalis sphingomyelinase C 2 precursor, putative 0.0004 0.0125 0.0366
Trichomonas vaginalis chromodomain-helicase-DNA-binding protein, putative 0.0006 0.0542 0.1789
Loa Loa (eye worm) exodeoxyribonuclease III family protein 0.002 0.2948 0.3578
Entamoeba histolytica inositol polyphosphate-5-phosphatase, putative 0.0004 0.0125 0.0424
Schistosoma mansoni ap endonuclease 0.002 0.2948 0.2948
Trichomonas vaginalis carbon catabolite repressor protein, putative 0.0004 0.0125 0.0366
Plasmodium falciparum endonuclease/exonuclease/phosphatase family protein, putative 0.0004 0.0125 0.0424
Schistosoma mansoni cpg binding protein 0.003 0.4688 0.4688
Trichomonas vaginalis skeletal muscle/kidney enriched inositol 5-phosphatase, putative 0.0004 0.0125 0.0366
Echinococcus multilocularis histone lysine N methyltransferase MLL3 0.0007 0.0651 0.0667
Trichomonas vaginalis conserved hypothetical protein 0.0006 0.0542 0.1789
Trichomonas vaginalis conserved hypothetical protein 0.0006 0.0542 0.1789
Echinococcus granulosus guanine nucleotide binding protein Gs subunit 0.0048 0.8014 1
Trichomonas vaginalis chromodomain helicase DNA binding protein, putative 0.0006 0.0542 0.1789
Trichomonas vaginalis carbon catabolite repressor protein, putative 0.0004 0.0125 0.0366
Plasmodium falciparum exodeoxyribonuclease III, putative 0.0004 0.0125 0.0424
Echinococcus granulosus histone lysine N methyltransferase MLL3 0.0007 0.0651 0.0667
Brugia malayi CXXC zinc finger family protein 0.0028 0.4403 0.5423
Schistosoma mansoni neutral sphingomyelinase 0.0004 0.0125 0.0125
Trichomonas vaginalis conserved hypothetical protein 0.0006 0.0542 0.1789
Brugia malayi GTP-binding regulatory protein Gs alpha-S chain, putative 0.0048 0.8014 1
Loa Loa (eye worm) CXXC zinc finger family protein 0.0028 0.4403 0.5423
Schistosoma mansoni ocrl type II inositol 5-phosphatase 0.0004 0.0125 0.0125
Schistosoma mansoni cript-related 0.0004 0.0125 0.0125
Echinococcus granulosus guanine nucleotide binding protein Gs subunit 0.0048 0.8014 1
Schistosoma mansoni synaptojanin 0.0004 0.0125 0.0125
Plasmodium falciparum AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative 0.002 0.2948 1
Schistosoma mansoni hypothetical protein 0.0004 0.0125 0.0125
Plasmodium falciparum DNase I-like protein, putative 0.0004 0.0125 0.0424
Echinococcus multilocularis DNA (apurinic or apyrimidinic site) lyase 0.002 0.2948 0.3578
Entamoeba histolytica endonuclease/exonuclease/phosphatase domain containing protein 0.0004 0.0125 0.0424
Echinococcus granulosus DNA apurinic or apyrimidinic site lyase 0.002 0.2948 0.3578
Trypanosoma cruzi apurinic/apyrimidinic endonuclease 0.002 0.2948 1
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.0048 0.8014 0.8014
Trichomonas vaginalis conserved hypothetical protein 0.0006 0.0542 0.1789
Plasmodium falciparum carbon catabolite repressor protein 4, putative 0.0004 0.0125 0.0424
Wolbachia endosymbiont of Brugia malayi exonuclease III 0.002 0.2948 0.5
Schistosoma mansoni nocturnin 0.0004 0.0125 0.0125
Trichomonas vaginalis conserved hypothetical protein 0.0006 0.0542 0.1789
Entamoeba histolytica exodeoxyribonuclease III, putative 0.002 0.2948 1
Loa Loa (eye worm) GTP-binding regulatory protein Gs alpha-S chain 0.0048 0.8014 1
Loa Loa (eye worm) histone methyltransferase 0.0009 0.0956 0.1053
Entamoeba histolytica endonuclease/exonuclease/phosphatase family protein 0.0004 0.0125 0.0424
Entamoeba histolytica endonuclease/exonuclease/phosphatase family protein 0.0004 0.0125 0.0424
Trichomonas vaginalis ap endonuclease, putative 0.002 0.2948 1
Schistosoma mansoni ap endonuclease 0.002 0.2948 0.2948
Entamoeba histolytica endonuclease/exonuclease/phosphatase domain containing protein 0.0004 0.0125 0.0424
Trichomonas vaginalis conserved hypothetical protein 0.0006 0.0542 0.1789
Trichomonas vaginalis ap endonuclease, putative 0.002 0.2948 1
Trichomonas vaginalis conserved hypothetical protein 0.0006 0.0542 0.1789
Entamoeba histolytica endonuclease/exonuclease/phosphatase family protein 0.0004 0.0125 0.0424
Trichomonas vaginalis chromodomain helicase DNA binding protein, putative 0.0006 0.0542 0.1789
Trichomonas vaginalis Phospholipase C precursor, putative 0.0004 0.0125 0.0366
Schistosoma mansoni cpg binding protein 0.003 0.4688 0.4688
Echinococcus multilocularis histone lysine N methyltransferase MLL3 0.0009 0.0956 0.1053
Onchocerca volvulus 0.0028 0.4403 1
Brugia malayi exodeoxyribonuclease III family protein 0.002 0.2948 0.3578
Trypanosoma cruzi apurinic/apyrimidinic endonuclease, putative 0.002 0.2948 1
Toxoplasma gondii exonuclease III APE 0.002 0.2948 0.3229
Echinococcus multilocularis guanine nucleotide binding protein G(s) subunit 0.0048 0.8014 1
Schistosoma mansoni cpg binding protein 0.0028 0.4403 0.4403
Trichomonas vaginalis ocrl type II inositol 5-phosphatase, putative 0.0004 0.0125 0.0366
Mycobacterium ulcerans exodeoxyribonuclease III protein XthA 0.002 0.2948 0.5
Plasmodium falciparum carbon catabolite repressor protein 4, putative 0.0004 0.0125 0.0424
Echinococcus granulosus histone lysine N methyltransferase MLL3 0.0009 0.0956 0.1053
Trichomonas vaginalis helicase, putative 0.0006 0.0542 0.1789
Entamoeba histolytica endonuclease/exonuclease/phosphatase family protein 0.0004 0.0125 0.0424
Trichomonas vaginalis conserved hypothetical protein 0.0006 0.0542 0.1789
Trypanosoma brucei apurinic/apyrimidinic endonuclease, putative 0.002 0.2948 1
Echinococcus granulosus mixed lineage leukemia protein mll 0.0007 0.0651 0.0667
Giardia lamblia Endonuclease/Exonuclease/phosphatase 0.002 0.2948 1
Trichomonas vaginalis carbon catabolite repressor protein, putative 0.0004 0.0125 0.0366
Echinococcus multilocularis guanine nucleotide binding protein G(s) subunit 0.0048 0.8014 1
Schistosoma mansoni mixed-lineage leukemia protein mll 0.0004 0.0127 0.0127
Toxoplasma gondii histone lysine methyltransferase SET1 0.0053 0.8869 1
Trichomonas vaginalis type II inositol 5-phosphatase, putative 0.0004 0.0125 0.0366
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.0048 0.8014 0.8014
Entamoeba histolytica inositol polyphosphate 5-phosphatase, putative 0.0004 0.0125 0.0424
Trichomonas vaginalis chromodomain helicase DNA binding protein, putative 0.0006 0.0542 0.1789

Activities

Activity type Activity value Assay description Source Reference
GI50 (functional) = 0.6 uM Cytotoxicity against human A549 cells expressing wild type p53 after 48 hrs by SRB assay ChEMBL. 19715319
GI50 (functional) = 1.4 uM Cytotoxicity against p53-deficient human HeLa cells after 48 hrs by SRB assay ChEMBL. 19715319
GI50 (functional) = 1.5 uM Cytotoxicity against human HepG2 cells expressing wild type p53 after 48 hrs by SRB assay ChEMBL. 19715319
GI50 (functional) = 2.6 uM Cytotoxicity against human AGS cells expressing wild type p53 after 48 hrs by SRB assay ChEMBL. 19715319
GI50 (functional) = 2.6 uM Cytotoxicity against estrogen receptor-positive human MCF7 cells expressing wild type p53 after 48 hrs by SRB assay ChEMBL. 19715319
GI50 (functional) = 4.2 uM Cytotoxicity against human HT-29 cells expressing p53 mutant after 48 hrs by SRB assay ChEMBL. 19715319
GI50 (functional) = 7.9 uM Cytotoxicity against p53-deficient human PC3 cells after 48 hrs by SRB assay ChEMBL. 19715319
IC50 (functional) = 1.1 uM Cytotoxicity against human Bel7402 cells after 48 hrs by MTT assay ChEMBL. 19715319
IC50 (functional) = 2.3 uM Cytotoxicity against human KB cells after 48 hrs by MTT assay ChEMBL. 19715319
IC50 (functional) = 2.3 uM Cytotoxicity against human A2780 cells after 48 hrs by MTT assay ChEMBL. 19715319
IC50 (functional) = 2.4 uM Cytotoxicity against p53-deficient human HeLa cells after 48 hrs by SRB assay ChEMBL. 19715319
IC50 (functional) = 2.4 uM Cytotoxicity against human A549 cells expressing wild type p53 after 48 hrs by SRB assay ChEMBL. 19715319
IC50 (functional) = 4.2 uM Cytotoxicity against human HepG2 cells expressing wild type p53 after 48 hrs by SRB assay ChEMBL. 19715319
IC50 (functional) = 4.7 uM Cytotoxicity against p53-deficient human K562 cells after 48 hrs by SRB assay ChEMBL. 19715319
IC50 (functional) = 4.9 uM Cytotoxicity against estrogen receptor-positive human MCF7 cells expressing wild type p53 after 48 hrs by SRB assay ChEMBL. 19715319
IC50 (functional) = 7.5 uM Cytotoxicity against human HT-29 cells expressing p53 mutant after 48 hrs by SRB assay ChEMBL. 19715319
IC50 (functional) = 7.8 uM Cytotoxicity against human THP1 cells expressing p53 mutant after 48 hrs by SRB assay ChEMBL. 19715319
IC50 (functional) = 8.2 uM Cytotoxicity against human AGS cells expressing wild type p53 after 48 hrs by SRB assay ChEMBL. 19715319
IC50 (functional) = 9.6 uM Cytotoxicity against p53-deficient human PC3 cells after 48 hrs by SRB assay ChEMBL. 19715319
IC50 (functional) > 10 uM Cytotoxicity against human U937 cells expressing p53 mutant after 48 hrs by SRB assay ChEMBL. 19715319

Phenotypes

Whole-cell/tissue/organism interactions

Species name Source Reference Is orphan
Homo sapiens ChEMBL23 19715319

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.